Literature DB >> 7866071

Finding a way through the cost and benefit maze.

A Szczepura.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7866071      PMCID: PMC2541882          DOI: 10.1136/bmj.309.6965.1314

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Cost-utility analysis of thrombolytic therapy.

Authors:  M L Simoons; J Vos; L L Martens
Journal:  Eur Heart J       Date:  1991-06       Impact factor: 29.983

2.  Use of claims data to monitor patients over time: acute myocardial infarction as a case study.

Authors:  B J McNeil
Journal:  Ann N Y Acad Sci       Date:  1993-12-31       Impact factor: 5.691

Review 3.  Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris.

Authors:  J McMurray; A Rankin
Journal:  BMJ       Date:  1994-11-19

4.  Purchasing clinically effective care.

Authors:  J Hayward
Journal:  BMJ       Date:  1994-10-01

5.  Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands.

Authors:  F Vermeer; M L Simoons; C de Zwaan; G A van Es; F W Verheugt; A van der Laarse; D C van Hoogenhuyze; A J Azar; F J van Dalen; J Lubsen
Journal:  Br Heart J       Date:  1988-05
  5 in total
  2 in total

1.  Economic evaluation in rheumatology: a necessity for clinical studies.

Authors:  B Griffiths; P Emery; R Akehurst
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

2.  Clinical guidelines in 1994.

Authors:  G Feder
Journal:  BMJ       Date:  1994-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.